Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_assertion type Assertion NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_head.
- NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_assertion description "[In follow-up analyses of the sample of patients, the prognostic value of securin was compared with the established markers of breast cancer proliferation, Ki-67 and mitotic activity index (MAI).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_provenance.
- NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_assertion evidence source_evidence_literature NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_provenance.
- NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_assertion SIO_000772 18594525 NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_provenance.
- NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_assertion wasDerivedFrom befree-20140225 NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_provenance.
- NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_assertion wasGeneratedBy ECO_0000203 NP458471.RAPXhb01H-EJY5DIwtoypaCCGxFb593amNtwNIQ0MEnXA130_provenance.